Articles/ Deep Dive/ Pharma Market Access/ Views and analysis Accessing biosimilars: untapped potential in EU and US Linda Banks biosimilars, drug market access, Drug regulation, market access, regulatory pathway 0 Comment Though they can reduce the costs of health care, biosimilars still face challenges to access. Share X Accessing biosimilars: untapped potential in EU and US https://pharmaphorum.com/views-and-analysis/accessing-biosimilars-untapped-potential-eu-us/